Jacob et al. were interested in the role of SFRP4 in ovarian cancer and next to SFRP4 expression levels in tumors and cell-lines they published SFRP4 plasma levels which are about 100-fold higher than in the other studies. This evidence concerns the gene SFRP4 and ovarian carcinoma.